{
    "clinical_study": {
        "@rank": "41668", 
        "biospec_descr": {
            "textblock": "cancer tissues"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Study hypothesis is that inhibition of Bv8 production in bone marrow cells of a mice wil\n      reduce the rate of growth of a primary human tumor implanted in the mice. we will take mice\n      and transform their bone marrow cells into non-Bv8 producing cells. than we will implant\n      primary human tumor tissue (taken from surgical specimens after informed consent)in those\n      mice and follow-up on the mice."
        }, 
        "brief_title": "Tissue Study of Bv8/PK-2 Inhibition in Human Cancer", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cancer", 
        "detailed_description": {
            "textblock": "1-10 grams of human cancer tissue will be taken from surgical specimen without interference\n      to the pathological data gathering process. those tissues will be implanted in nude mice\n      that will either be treated with anti-Bv8 antibodies or will be transplanted with bone\n      marrow in which Bv8 expression is silenced."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ages 18-85 years\n\n          -  Pathologically-confirmed diagnosis of pancreatic ductal adenocarcinoma undergoing\n             surgical pancreaticoduodenectomy\n\n        Exclusion Criteria:\n\n          -  refuse to take part\n\n          -  preoperative chemotherapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients diagnosed with pancreatic cancer and are candidates for whipple's procedure"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656824", 
            "org_study_id": "Bv8/PK-2CTIL"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bv8/PK-2", 
            "MDSC Myeloid Derived Suppressor Cells", 
            "BMDC Bone Marrow Derived Cells", 
            "Angiogenesis", 
            "Pancreatic Cancer"
        ], 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "contact": {
                "email": "e_hasnis@rambam.health.gov.il", 
                "last_name": "Erez Hasnis, MD;PhD", 
                "phone": "972-50-2061911"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Rambam Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Human Primary Cancer Tissue Implanted in Mice Lacking Bv8/PH-2 in Their Bone Marrow-derived Cells", 
        "overall_contact": {
            "email": "e_hasnis@rambam.health.gov.il", 
            "last_name": "Erez Hasnis, MD; PhD", 
            "phone": "972-50-2061911"
        }, 
        "overall_official": [
            {
                "affiliation": "Rambam Health Care Campus", 
                "last_name": "Erez Hasnis, MD;PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rambam Health Care Campus", 
                "last_name": "Erez Hasnis, MD; PhD.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Tumor growth in xenograft model", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656824"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}